BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22399165)

  • 1. [Investigation of the frequency of PER-1 type beta-lactamase and antimicrobial resistance rates in nosocomial isolates of Pseudomonas aeruginosa].
    Atilla A; Eroğlu C; Esen S; Sünbül M; Leblebicioğlu H
    Mikrobiyol Bul; 2012 Jan; 46(1):1-8. PubMed ID: 22399165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections.
    Van Eldere J
    J Antimicrob Chemother; 2003 Feb; 51(2):347-52. PubMed ID: 12562701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary study on metallo-beta-lactamase producing Pseudomonas aeruginosa in hospitalized patients.
    Navaneeth BV; Sridaran D; Sahay D; Belwadi MR
    Indian J Med Res; 2002 Dec; 116():264-7. PubMed ID: 12807154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].
    Wang H; Chen MJ;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):385-90. PubMed ID: 12820914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study].
    Cavallo JD; Leblanc F; Fabre R
    Pathol Biol (Paris); 2000 Jun; 48(5):472-7. PubMed ID: 10949844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nosocomial spread of the integron-located veb-1-like cassette encoding an extended-pectrum beta-lactamase in Pseudomonas aeruginosa in Thailand.
    Girlich D; Naas T; Leelaporn A; Poirel L; Fennewald M; Nordmann P
    Clin Infect Dis; 2002 Mar; 34(5):603-11. PubMed ID: 11807680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).
    Jones RN; Kirby JT; Beach ML; Biedenbach DJ; Pfaller MA
    Diagn Microbiol Infect Dis; 2002 Jul; 43(3):239-43. PubMed ID: 12106958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the antibiotic susceptibility patterns of pathogens causing nosocomial infections.
    Yaman A; Tasova Y; Kibar F; Inal AS; Saltoglu N; Buyukcelik O; Kurtaran B; Dundar IH
    Saudi Med J; 2004 Oct; 25(10):1403-9. PubMed ID: 15494811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
    Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P
    Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sensitivity to antibiotics of bacteria from nosocomial infections. Evolution in resuscitation services of military hospitals].
    Garrabé E; Cavallo JD; Brisou P; Chapalain JC; Coué JC; Courrier P; Granic G; Hervé V; Koeck JL; Morillon M; Claude JD; Rouby Y; Teyssou R
    Presse Med; 2000 Sep; 29(27):1497-503. PubMed ID: 11045115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group.
    Jones RN; Pfaller MA; Doern GV; Erwin ME; Hollis RJ
    Diagn Microbiol Infect Dis; 1998 Mar; 30(3):215-28. PubMed ID: 9572029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase.
    Luzzaro F; Mantengoli E; Perilli M; Lombardi G; Orlandi V; Orsatti A; Amicosante G; Rossolini GM; Toniolo A
    J Clin Microbiol; 2001 May; 39(5):1865-70. PubMed ID: 11326005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated in Fukushima Prefecture].
    Niitsuma K; Saitoh M; Kojimabara M; Kashiwabara N; Aoki T; Tomizawa M; Maeda J; Kosenda T
    Jpn J Antibiot; 2001 Feb; 54(2):79-87. PubMed ID: 11338681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A control study on bacterial resistance and clinical features of lower respiratory tract infection with Pseudomonas aeruginosa in medical intensive care unit and general ward].
    Shao C; Qu J; He L; Ni C; Hu B
    Zhonghua Nei Ke Za Zhi; 2002 Dec; 41(12):813-7. PubMed ID: 12654234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Survey of the antibiotic sensitivity of Pseudomonas aeruginosa in France and the distribution of beta-lactam resistance mechanisms: the GERPB 1999 study].
    Cavallo JD; Leblanc F; Fabre R; Fourticq-Esqueöute A;
    Pathol Biol (Paris); 2001 Sep; 49(7):534-9. PubMed ID: 11642015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility patterns in Pseudomonas aeruginosa: data from a multicenter Intensive Care Unit Surveillance Study (ISS) in the United States.
    Friedland I; Gallagher G; King T; Woods GL
    J Chemother; 2004 Oct; 16(5):437-41. PubMed ID: 15565908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial outbreak of extended-spectrum beta-lactamase SHV-5-producing isolates of Pseudomonas aeruginosa in Athens, Greece.
    Poirel L; Lebessi E; Castro M; Fèvre C; Foustoukou M; Nordmann P
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2277-9. PubMed ID: 15155233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance.
    Dubois V; Arpin C; Melon M; Melon B; Andre C; Frigo C; Quentin C
    J Clin Microbiol; 2001 Jun; 39(6):2072-8. PubMed ID: 11376037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Susceptibility of Pseudomonas aeruginosa to antibiotics isolated from patients of intensive care units in France in 1998. Resistant phenotypes to beta-lactams].
    Rio Y; Pina P; Jurin F; Allouch P; Didion J; Chardon H; Chiche D;
    Pathol Biol (Paris); 2002 Feb; 50(1):12-7. PubMed ID: 11873623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.